FFA
IHE icon

Founders Financial Alliance’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Founders Financial Alliance’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-600
Closed -$40.7K – 569
2024
Q1 		$40.7K Buy
+600
New +$39.7K 0.01% 397

Other funds holding IHE

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
ACA
Aptus Capital Advisors Fairhope, Alabama $14.6B AUM 22.78% 1-Year Est. Return
RW
Rockport Wealth Fairview Park, Ohio $595M AUM 23.65% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Founders Financial Alliance's IHE Position: Q2 2024 in Review

Founders Financial Alliance sold out of iShares US Pharmaceuticals ETF (IHE) in Q2 2024, closing a stake of 600 shares — an estimated $40.7K sold.

Founders Financial Alliance first reported a position in IHE in Q1 2024 and held it in 1 quarter. The position peaked at $40.7K in Q1 2024. 143 funds tracked by Wall St. Rank hold IHE as of Q2 2024.

  • Founders Financial Alliance reported no remaining iShares US Pharmaceuticals ETF position as of Q2 2024 after selling out during the quarter.
  • Founders Financial Alliance sold 600 iShares US Pharmaceuticals ETF shares in Q2 2024, an estimated $40.7K.
  • Founders Financial Alliance first reported a position in iShares US Pharmaceuticals ETF in Q1 2024 and held it in 1 quarter.
  • Founders Financial Alliance's iShares US Pharmaceuticals ETF position peaked at $40.7K in Q1 2024.
  • 143 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2024.

Based on Founders Financial Alliance's 13F filing for Q2 2024, filed 26 Aug 2024.